MediGene, Eczacibasi sales and marketing update

MediGene granted Eczacibasi's EIP Eczacibasi Ilac Pazarlama A/S subsidiary exclusive rights to commercialize genital wart drug Veregen sinecatechins ointment in Turkey. MediGene is eligible for regulatory and sales milestones as well as double-digit royalties. EIP will be responsible for regulatory approval in Turkey. Details were not disclosed. ...